RSV (Respiratory Syncytial Virus)

Clinical Resources

Materials for Providers

Standing Orders for Administering Nirsevimab RSV Preventive Antibody to Infants

Eligible healthcare professionals may vaccinate infants who meet any of the criteria on this form

Standing Orders for Administering Pfizer Respiratory Syncytial Virus (RSV) Vaccine (Abrysvo) During Pregnancy

Eligible healthcare professionals may vaccinate pregnant persons who meet any of the criteria on this form

View all Clinical Resources

CDC · FDA · State

ACIP Recommendations

Current Recommendations

Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus–Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023
MMWR, October 13, 2023, 72(41);1115-1122
Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices—United States, 2023
MMWR, August 25, 2023, 72(34); 920–925
Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices
MMWR, July 21, 2023, 72 (29); 793-801

Vaccine Information Statements

Immunization Information Statement (IIS) – Respiratory Syncytial Virus (RSV) Preventive Antibody VIS
Updated: September 25, 2023
RSV (Respiratory Syncytial Virus) Vaccine VIS
Updated: October 19, 2023

FDA Package Inserts & EUAs

RSV: Mrsevia Package Insert
Moderna
RSV: Beyfortus Package Insert
Sanofi
RSV: Arexvy Package Insert
GSK
RSV: Abrysvo Package Insert
Pfizer

More from Immunize.org

This page was updated on .